KPV

KPV (Lys-Pro-Val) is a tripeptide fragment of alpha-melanocyte stimulating hormone (α-MSH). Despite being only three amino acids, it retains potent anti-inflammatory and antimicrobial properties of the parent hormone.

KPV is the tiny three-letter peptide everyone in gut-health and skin-inflammation research talks about. It is short, stable, and quietly powerful — the calm-it-down peptide of the inflammation world.

Enters cells and acts intracellularly to inhibit NF-κB signaling and downstream pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). It also exhibits direct antimicrobial activity against multiple bacterial and fungal strains. Its small size supports oral bioavailability for gut-focused research.

• •Inflammatory bowel disease (IBD) models
• •Topical inflammation and wound healing
• •Antimicrobial activity studies
• •Gut barrier integrity research
• •Comparison with BPC-157 and LL-37

A growing favorite in gut-health, IBD-research, and biohacker communities. Common discussion: oral capsules for gut research, topical formulations for skin, and how it compares to BPC-157 for inflammation endpoints.

“Three-letter calm-down for inflamed tissue.”

Often stacked with BPC-157 for gut research, with LL-37 for antimicrobial conversations, and with Thymosin Alpha-1 for broader immune modulation.

KPV is the C-terminal tripeptide fragment of α-MSH, studied for intracellular NF-κB suppression, antimicrobial activity, and gut/skin inflammation research.